Synvect’s CEO, cofounder, and tech inventor, Nikolay Kandul, gave an amazing talk at the AMCD today! Synvect leverages SIT and CRISPR gene knockouts to suppress dangerous mosquito populations. If you have questions, let me know via a quick DM or email ([email protected])

This week Synvect and Nikolay Kandul are at the Genetic Biocontrol GRC, created for the advancement of public health via genetic solutions. Learn more about how Synvect eliminates vector-borne disease via CRISPR by DM'ing me or visiting synvect.com.

Synvect's CEO, Nikolay Kandul, ran into some of our research partners at the Genetic Biocontrol GRC! Hervé Bossin and his team are working with Synvect on assessing our tech's impact on mosquito populations in French Polynesia. Email [email protected] to learn more.

Our CEO, Nikolay Kandul , chatted about Synvect at the Genetic Biocontrol GRC in Barcelona, Spain! We are proud to be a sponsor of the GRC alongside impact powerhouses like the Gates Foundation , Open Philanthropy , and others.